Schizophrenia

Prenatal expression patterns of genes associated with neuropsychiatric disorders.

Birnbaum R, Jaffe AE, Hyde TM, Kleinman JE, Weinberger DR. Prenatal expression patterns of genes associated with neuropsychiatric disorders. Am J Psychiatry. 2014;171(7):758-67. DOI: 10.1176/appi.ajp.2014.13111452. PubMed PMID: 24874100.

Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268.

Kimoto S, Bazmi HH, Lewis DA. Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am J Psychiatry. 2014;171(9):969-78. DOI: 10.1176/appi.ajp.2014.14010004. PubMed PMID: 24874453.

Increased platelet intracellular calcium ion concentration is specific to bipolar disorder.

Dubovsky SL, Daurignac E, Leonard KE. Increased platelet intracellular calcium ion concentration is specific to bipolar disorder. J Affect Disord. 2014;164:38-42. DOI: 10.1016/j.jad.2014.04.025. PubMed PMID: 24856551.

Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.

McEvoy JP, Byerly M, Hamer RM, Dominik R, Swartz MS, Rosenheck RA, et al. Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. JAMA. 2014;311(19):1978-87. DOI: 10.1001/jama.2014.4310. PubMed PMID: 24846035.

Physical activity interventions for people with mental illness: a systematic review and meta-analysis.

Rosenbaum S, Tiedemann A, Sherrington C, Curtis J, Ward PB. Physical activity interventions for people with mental illness: a systematic review and meta-analysis. J Clin Psychiatry. 2014;75(9):964-74. DOI: 10.4088/JCP.13r08765. PubMed PMID: 24813261.

Schizophrenia: mechanism of action of current and novel treatments.

Correll CU, Kane JM. Schizophrenia: mechanism of action of current and novel treatments. J Clin Psychiatry. 2014;75(4):347-8. DOI: 10.4088/JCP.13078co8c. PubMed PMID: 24813403.

The impact of cannabis and stimulant disorders on diagnostic stability in psychosis.

Sara GE, Burgess PM, Malhi GS, Whiteford HA, Hall WC. The impact of cannabis and stimulant disorders on diagnostic stability in psychosis. J Clin Psychiatry. 2014;75(4):349-56. DOI: 10.4088/JCP.13m08878. PubMed PMID: 24813404.

Recognizing primary vs secondary negative symptoms and apathy vs expression domains.

Kirkpatrick B. Recognizing primary vs secondary negative symptoms and apathy vs expression domains. J Clin Psychiatry. 2014;75(4):e09. DOI: 10.4088/JCP.13049tx3c. PubMed PMID: 24813410.

Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials.

Rabinowitz J, Werbeloff N, Caers I, Mandel FS, Stauffer V, Ménard F, et al.. Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials. J Clin Psychiatry. 2014;75(4):e308-16. DOI: 10.4088/JCP.13m08853. PubMed PMID: 24813414.

Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: analysis of amisulpride vs placebo in three clinical trials.

Levine SZ, Leucht S. Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: analysis of amisulpride vs placebo in three clinical trials. Schizophr Res. 2014;156(1):107-14. DOI: 10.1016/j.schres.2014.04.005. PubMed PMID: 24794879.